Treatment of hepatorenal syndrome

Treatment of hepatorenal syndrome

Saved in:

Bibliographic Details
Main Authors:	Kezić Aleksandra, Mijač Dragana, Stojimirović Biljana
Format:	Article
Language:	English
Published:	Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2007-01-01
Series:	Vojnosanitetski Pregled
Subjects:	hepatorenal syndrome drug therapy vasoconstrictor agents dialysis portasystemic shunt transjugular intrahepatic liver transplantation treatment outcome
Online Access:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2007/0042-84500711773K.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An Update on Hepatorenal Syndrome
by: Samuel Chan, et al.
Published: (2017-03-01)

Treating systemic inflammation by transjugular intrahepatic portosystemic shunt: Editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
by: Georg Semmler, et al.
Published: (2025-04-01)

HEPATORENAL SYNDROME WITH ACUTE RENAL FAILURE IN PATIENTS WITH CHRONIC LIVER DISEASE: MODERN ASPECTS OF CLINICAL PRESENTATION AND INTENSIVE CARE
by: R. R. Nagimullin, et al.
Published: (2018-08-01)

The possibilities of interventional radiology before and after orthotopic liver transplantation
by: A. V. Moiseenko, et al.
Published: (2018-09-01)

MesoTIPS: Combined approach for the treatment of portal hypertension secondary to portal vein thrombosis – A brief report
by: Abbas Chamsuddin, et al.
Published: (2017-01-01)

MesoTIPS: Combined Approach for the Treatment of Portal Hypertension Secondary to Portal Vein Thrombosis – A Brief Report
by: Abbas Chamsuddin, et al.
Published: (2017-01-01)

Outcome of Transjugular Intrahepatic Portosystemic Shunt in Budd-Chiari Syndrome: Long-Term Outcomes of 118 Patients; A Single-center Experience
by: Mohamed Shaker, et al.
Published: (2018-07-01)

Decreasing systemic inflammation after TIPS: Still hope for the liver: Reply to correspondence on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
by: Georg Semmler, et al.
Published: (2025-04-01)

Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension complications: A single-center retrospective cohort
by: Jianbin Zhang, MD, et al.
Published: (2025-01-01)

A rare case of Gynura-segetum-related hepatic sinus obstruction syndrome complicated with alcoholic liver disease
by: Yidan Gao, et al.
Published: (2024-06-01)

Hepatorenal syndrome: a Nationwide Trend Analysis from 2008 to 2018
by: Jagmeet Singh, et al.
Published: (2021-01-01)

Transjugular Intrahepatic Portosystemic Shunt Reduction for Medically Refractory Hepatic Encephalopathy
by: Brandon Toliver, et al.
Published: (2024-08-01)

Minimal residual ascites 3 months after TIPS implantation implicates worse clinical outcomes in patients with cirrhosis
by: Jim Benjamin Mauz, et al.
Published: (2025-07-01)

Hepatic encephalopathy post-TIPS: Current status and prospects in predictive assessment
by: Xiaowei Xu, et al.
Published: (2024-12-01)

Portal Vein Thrombosis in Liver Cirrhosis. Part 2: Treatment, Primary and Secondary Prevention
by: A. V. Yagoda, et al.
Published: (2024-08-01)

TIPS insertion and systemic inflammation: Is it ever too late to lower portal pressure? Correspondence to editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
by: Anja Tiede, et al.
Published: (2025-04-01)

Systemic reviews and meta-analysis of the use of midodrine in hepatorenal syndrome
by: Prem Balaji Reddy Lankapothu, et al.
Published: (2024-09-01)

Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)
by: M.I. Tutchenko, et al.
Published: (2024-06-01)

Renal recovery following orthotopic liver transplant after prolonged kidney injury: Perspectives on diagnosing hepatorenal syndrome and determining which patients should undergo simultaneous liver kidney transplantation
by: Mary Elizabeth Card, et al.
Published: (2017-07-01)

Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation
by: Laura Büttner, et al.
Published: (2025-06-01)

Transjugular Intrahepatic Portosystemic Shunt (TIPS): bridging the gap from bench to bedside
by: Citra Indriani Sibarani, et al.
Published: (2025-06-01)

Portal vein velocity and its dynamics: a potentially useful tool for detecting clinically silent transjugular intrahepatic porto-systemic shunt dysfunction using Doppler ultrasonography
by: Rareș Crăciun, et al.
Published: (2024-01-01)

Repeat Stent Placement through Lateral Fenestration of the Existing Dysfunctioning DIPS Stent Graft: An Alternative to Parallel TIPS/DIPS Procedure in a Case of Blocked Primary TIPS/DIPS
by: Karan Manoj Anandpara, et al.
Published: (2020-08-01)

Cirrhotic cardiomyopathy
by: S. N. Mammayev, et al.
Published: (2010-06-01)

Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis
by: Anja Tiede, et al.
Published: (2025-01-01)

Muscle fat content correlates with postoperative survival of viral-related cirrhosis patients after the TIPS: a retrospective study
by: Sai Li, et al.
Published: (2025-12-01)

Development and validation of a machine learning-based model to predict survival in patients with cirrhosis after transjugular intrahepatic portosystemic shuntResearch in context
by: Binlin Da, et al.
Published: (2025-01-01)

Transjugular intrahepatic portosystemic shunt: a meta-analysis of 8 mm versus 10 mm stents
by: Ping-Chao Huang, et al.
Published: (2021-03-01)

Transjugular intrahepatic portosystemic shunt with gastric vein embolization in liver cirrhosis
by: V. I. Korobka, et al.
Published: (2024-09-01)

Trans-splenic Approach for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation in Patients with Portal Vein Thrombosis
by: Maryam Boumezrag, et al.
Published: (2024-07-01)

Controlled expansion stent grafts versus legacy stent grafts for transjugular intrahepatic portosystemic shunt: a single-centre retrospective study on the incidence of hepatic encephalopathy
by: Afonso Fonseca, et al.
Published: (2025-05-01)

Prevalence and influence factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a Meta-analysis
by: TANG Yuhan, et al.
Published: (2025-01-01)

Perinatal Outcomes According to the Type of Prenatally Diagnosed Umbilical-Portal-Systemic Venous Shunt
by: Jinha Chung, et al.
Published: (2022-10-01)

Inferior vena cava obstruction secondary to hepatic alveolar echinococcosis: a case report
by: Jingxin Yan
Published: (2025-04-01)

Efficacy and safety of transjugular intrahepatic portosystemic shunt in hepatic sinusoidal obstruction syndrome: systematic review and meta-analysis
by: Xinghe Jiang, et al.
Published: (2025-08-01)

Diagnostical significance of dimethylarginine in the development of hepatorenal syndrome in patients with alcoholic liver cirrhosis
by: Ničković Vanja, et al.
Published: (2012-01-01)

Gut microbiome alterations and hepatic encephalopathy post-TIPS in liver cirrhosis patients
by: Shengpeng Li, et al.
Published: (2025-07-01)

CLINICAL EFFICACY OF ALBUMIN DIALYSIS THERAPY FOR PATIENTS WITH HEPATORENAL SYNDROME
by: D. E. Kutepov, et al.
Published: (2009-06-01)

A GLIM-defined malnutrition-based model for predicting prognosis of cirrhotic patients with portal hypertension following TIPS procedure
by: Wen-Ting Huang, et al.
Published: (2025-08-01)

Safety and Efficacy of Overdilation of 10 mm Viatorr Transjugular Intrahepatic Portosystemic Shunt Stents Using 12 mm Balloons
by: Muhammad Mohid Tahir, et al.
Published: (2024-07-01)